Therapeutic efficacy of immunotherapy for gastric cancer metastasis

被引:0
|
作者
Xie, Fei-Fei [1 ]
Qian, Su-Ting [1 ]
Zhao, Hao-Yu [1 ]
Liu, Qing-Sheng [2 ]
机构
[1] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Dept Digest, Hangzhou 310007, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Sci & Educ Sect, 453 Stadium Rd, Hangzhou 310007, Zhejiang, Peoples R China
来源
关键词
Gastric cancer; Metastasis; Immunotherapy; Liver metastasis; Lung metastasis; Peritoneal metastasis; GASTROESOPHAGEAL JUNCTION; PLUS CHEMOTHERAPY; PD-L1; EXPRESSION; INHIBITORS;
D O I
10.4240/wjgs.v16.i12.3881
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastric cancer (GC) metastasis is the main cause of poor prognosis for GC patients. In recent years, breakthroughs in immunotherapy have been made in the treatment of many kinds of cancers, providing new hope for patients with GC metastasis. This paper reviews the mechanism of immunotherapy in GC metastasis and its clinical application, and discusses and compares the research and efficacy of immunotherapy in patients with liver metastasis, lung metastasis, peritoneal metastasis and lymph node metastasis of GC. This study explores the challenges and future development directions of immunotherapy, and provides a theoretical basis and clinical guidance for the precise treatment of patients with GC metastasis.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors
    Yang, Yu-Nuo
    Wang, Li-Sheng
    Dang, Yan-Qi
    Ji, Guang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (32)
  • [42] A potential EBV-related classifier is associated with the efficacy of immunotherapy in gastric cancer
    Xu, Yun-Yun
    Shen, Ao
    Zeng, Zhao-Lei
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 2084 - +
  • [43] Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on cholesterol metabolism in gastric cancer
    Zhu, Chengjun
    Yan, Mengpei
    Zhang, Zhijun
    Shen, Yikai
    Wang, Wangwen
    Chen, Zetian
    Cai, Changsheng
    Liu, Hongda
    Xu, Zekuan
    Li, Zheng
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
    Lin, Guang-Tan
    Huang, Jiao-Bao
    Lin, Ju-Li
    Lin, Jian-Xian
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lu, Jun
    Zheng, Chao-Hui
    Huang, Chang-Ming
    Li, Ping
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Efficacy of radiotherapy combined with targeted therapy and immunotherapy for lymph node metastasis of liver cancer
    Yan, Huamei
    Xu, Jianliang
    Li, Zhenghuan
    Li, Nuoya
    Guo, Xianyu
    Wu, Manya
    Wang, Donghui
    Lin, Nan
    Dong, Jie
    Xu, Xiangying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (04)
  • [46] Immunology and immunotherapy in gastric cancer
    Xiaqing Xu
    Jiaxing Chen
    Wenxing Li
    Chenlu Feng
    Qian Liu
    Wenfang Gao
    Meng He
    Clinical and Experimental Medicine, 2023, 23 : 3189 - 3204
  • [47] Updated Immunotherapy for Gastric Cancer
    Narita, Yukiya
    Muro, Kei
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [48] Immunology and immunotherapy in gastric cancer
    Xu, Xiaqing
    Chen, Jiaxing
    Li, Wenxing
    Feng, Chenlu
    Liu, Qian
    Gao, Wenfang
    He, Meng
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3189 - 3204
  • [49] Immunotherapy for metastatic gastric cancer
    Li, Chang-Fei
    Lian, Li-Li
    Li, Qiu-Ru
    Jiao, Yan
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (11):
  • [50] Immunotherapy for advanced gastric cancer
    Kang, Yoon-Koo
    ANNALS OF ONCOLOGY, 2018, 29